Rapid and large amount of autocrine IL-3 production is responsible for mast cell survival by IgE in the absence of antigen

Blood

Volumn 105, Issue 5, 2005, Pages 2059-2065

  Kohno, Masayuki ^a   Yamasaki, Sho ^a   Tybulewicz, Victor L J ^a   Saito, Takashi ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; HISTIDINE DECARBOXYLASE; IMMUNOGLOBULIN E; INTERLEUKIN 3; MEMBRANE PROTEIN; PROTEI GAB2; PROTEIN KINASE FYN; PROTEIN KINASE LYN; PROTEIN KINASE SYK; UNCLASSIFIED DRUG; BCL2L1 PROTEIN, MOUSE; DNA BINDING PROTEIN; ENZYME PRECURSOR; FC RECEPTOR; LYN PROTEIN-TYROSINE KINASE; MILK PROTEIN; PROTEIN BCL 2; PROTEIN BCL X; PROTEIN TYROSINE KINASE; SIGNAL PEPTIDE; STAT5 PROTEIN; TRANSACTIVATOR PROTEIN;

ANIMAL CELL; ARTICLE; AUTOCRINE EFFECT; BONE MARROW CELL; CELL SURVIVAL; GENE EXPRESSION; MAST CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; UPREGULATION; WILD TYPE; ANIMAL; BIOSYNTHESIS; C57BL MOUSE; CYTOLOGY; METABOLISM; PHYSIOLOGY;

ANIMALS; ANTIGENS; AUTOCRINE COMMUNICATION; BCL-X PROTEIN; BONE MARROW CELLS; CELL SURVIVAL; DNA-BINDING PROTEINS; ENZYME PRECURSORS; IMMUNOGLOBULIN E; INTERLEUKIN-3; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MAST CELLS; MICE; MICE, INBRED C57BL; MILK PROTEINS; PROTEIN-TYROSINE KINASES; PROTO-ONCOGENE PROTEINS C-BCL-2; RECEPTORS, IGG; SIGNAL TRANSDUCTION; SRC-FAMILY KINASES; STAT5 TRANSCRIPTION FACTOR; TRANS-ACTIVATORS;

EID: 14944357631     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood-2004-07-2639     Document Type: Article

References (58)

1. Turner H, Kinet JP. Signalling through the high-affinity IgE receptor Fc epsilon RI. Nature. 1999;402:624-30.
2. Conroy MC, Adkinson NF Jr, Lichtenstein LM. Measurement of IgE on human basophils: relation to serum IgE and anti-IgE-induced histamine release. J Immunol. 1977;1118:1317-1321.
3. Stallman PJ, Aalberse RC, Bruhl PC, van Elven EH. Experiments on the passive sensitization of human basophils, using quantitative immunofluorescence microscopy. Int Arch Allergy Appl Immunol. 1977;54:364-373.
4. Yamaguchi M, Lantz CS, Oettgen HC, et al. IgE enhances mouse mast cell Fc(epsilon)RI expression in vitro and in vivo: evidence for a novel amplification mechanism in IgE-dependent reactions. J Exp Med. 1997;185:663-672.
5. Asai K, Kitaura J, Kawakami Y, et al. Regulation of mast cell survival by IgE. Immunity. 2001;14:791-800.
6. Kalesnikoff J, Huber M, Lam V, et al. Monomeric IgE stimulates signaling pathways in mast cells that lead to cytokine production and cell survival. Immunity. 2001;14:801-811.
7. Furuichi K, Rivera J, Isersky C. The receptor for immunoglobulin E on rat basophilic leukemia cells: effect of ligand binding on receptor expression. Proc Natl Acad Sci USA. 1985;82:1522-1525.
8. Quarto R, Kinet JP, Metzger H. Coordinate synthesis and degradation of the alpha-, beta- and gamma-subunits of the receptor for immunoglobulin E. Mol Immunol. 1985;22:1045-1051.
9. Borkowski TA, Jouvin MH, Lin SY, Kinet JP. Minimal requirements for IgE-mediated regulation of surface Fc epsilon RI. J Immunol. 2001;167:1290-1296.
10. Kubo S, Matsuoka K, Taya C, et al. Drastic up-regulation of Fcepsilonri on mast cells is induced by IgE binding through stabilization and accumulation of Fcepsilonri on the cell surface. J Immunol. 2001;167:3427-3434.
11. Sakurai D, Yamasaki S, Arase K, et al. FcepsilonRI-gamma-ITAM is differentially required for mast cell function in vivo. J Immunol. 2004;172:2374-2381.
12. Yamasaki S, Ishikawa E, Kohno M, Saito T. The quantity and duration of FcR{gamma) signals determine mast cell degranulation and survival. Blood. 2004;103:3093-3101.
13. Rivera J. Molecular adapters in Fc(epsilon)RI signaling and the allergic response. Curr Opin Immunol. 2002;14:688-693.
14. Parravicini V, Gadina M, Kovarova M, et al. Fyn kinase initiates complementary signals required for IgE-dependent mast cell degranulation. Nat Immunol. 2002;3:741-748.
15. Gu H, Saito K, Klaman LD, etal. Essential role for Gab2 in the allergic response. Nature. 2001;412:186-190.
16. Nishida K, Yoshida Y, Itoh M, et al. Gab-family adapter proteins act downstream of cytokine and growth factor receptors and T- and B-cell antigen receptors. Blood. 1999;93:1809-1816.
17. Cantley LC. The phosphoinositide 3-kinase pathway. Science. 2002;296:1655-1657.
18. Kawakami T, Galli SJ. Regulation of mast-cell and basophil function and survival by IgE. Nat Rev Immunol. 2002;2:773-786.
19. Park SY, Saijo K, Takahashi T, et al. Developmental defects of lymphoid cells in Jak3 kinase-deficient mice. Immunity. 1995;3:771-782.
20. Nishida K, Wang L, Morii E, et al. Requirement of Gab2 for mast cell development and KitL/c-Kit signaling. Blood. 2002;99:1866-1869.
21. Yagi T, Aizawa S, Tokunaga T, Shigetani Y, Takeda N, Ikawa Y. A role for Fyn tyrosine kinase in the suckling behaviourof neonatal mice. Nature. 1993;366:742-745.
22. Nishizumi H, Taniuchi I, Yamanashi Y, et al. Impaired proliferation of peripheral B cells and indication of autoimmune disease in lyn-deficient mice. Immunity. 1995;3:549-560.
23. Suzuki H, Terauchi Y, Fujiwara M, et al. Xid-like immunodeficiency in mice with disruption of the p85alpha subunit of phosphoinositide 3-kinase. Science. 1999;283:390-392.
24. Turner M, Mee PJ, Costello PS, et al. Perinatal lethality and blocked B-cell development in mice lacking the tyrosine kinase Syk. Nature. 1995;378:298-302.
25. Onishi M, Nosaka T, Misawa K, et al. Identification and characterization of a constitutively active STAT5 mutant that promotes cell proliferation. Mol Cell Biol. 1998;18:3871-3879.
26. Liu FT, Bohn JW, Ferry EL, et al. Monoclonal dinitrophenyl-specific murine IgE antibody: preparation, isolation, and characterization. J Immunol. 1980;124:2728-2737.
27. Daeron M. Fc receptor biology. Annu Rev Immunol. 1997;15:203-234.
28. Kitaura J, Song J, Tsai M, et al. Evidence that IgE molecules mediate a spectrum of effects on mast cell survival and activation via aggregation of the FcepsilonRI. Proc Natl Acad Sci U S A. 2003;100:12911-12916.
29. Lu-Kuo JM, Fruman DA, Joyal DM, Cantley LC, Katz HR. Impaired kit- but not FcepsilonRI-initiated mast cell activation in the absence of phosphoinositide 3-kinase p85alpha gene products. J Biol Chem. 2000;275:6022-6029.
30. Fukao T, Yamada T, Tanabe M, et al. Selective loss of gastrointestinal mast cells and impaired immunity in PI3K-deficient mice. Nat Immunol. 2002;3:295-304.
31. Kawakami Y, Kitaura J, Satterthwaite AB, et al. Redundant and opposing functions of two tyrosine kinases, Btk and Lyn, in mast cell activation. J Immunol. 2000;165:1210-1219.
32. Kitaura J, Asai K, Maeda-Yamamoto M, Kawakami Y, Kikkawa U, Kawakami T. Akt-dependent cytokine production in mast cells. J Exp Med. 2000;192:729-740.
33. Flaut M, Pierce JH, Watson CJ, Hanley-Hyde J, Nordan RP, Paul WE. Mast cell lines produce lymphokines in response to cross-linkage of Fc epsilon RI or to calcium ionophores. Nature. 1989;339:64-67.
34. Lantz CS, Boesiger J, Song CH, et al. Role for interleukin-3 in mast-cell and basophil development and in immunity to parasites. Nature. 1998;392:90-93.
35. Hultner L, Druez C, Moeller J, et al. Mast cell growth-enhancing activity (MEA) is structurally related and functionally identical to the novel mouse T cell growth factor P40/TCGFlII (interleukin9). Eur J Immunol. 1990;20:1413-1416.
36. Suzuki K, Nakajima H, Watanabe N, et al. Role of common cytokine receptor gamma chain (gamma(c))- and Jak3-dependent signaling in the proliferation and survival of murine mast cells. Blood. 2000;96:2172-2180.
37. Godfraind C, Louahed J, Faulkner H, et al. Intraepithelial infiltration by mast cells with both connective tissue-type and mucosal-type characteristics in gut, trachea, and kidneys of IL-9 transgenic mice. J Immunol. 1998;160:3989-3996.
38. Temann UA, Geba GP, Rankin JA, Flavell RA. Expression of interleukin 9 in the lungs of transgenic mice causes airway inflammation, mast cell hyperplasia, and bronchial hyperresponsiveness. J Exp Med. 1998;188:1307-1320.
39. Lord JD, McIntosh BC, Greenberg PD, Nelson BH. The IL-2 receptor promotes lymphocyte proliferation and induction of the c-myc, bcl-2, and bcl-x genes through the trans-activation domain of Stat5. J Immunol. 2000;164:2533-2541.
40. -/- mice: a direct role for Stat5 in Bcl-X(L) induction. Cell. 1999;98:181-191.
41. Gesbert F, Griffin JD. Bcr/Abl activates transcription of the Bcl-X gene through STAT5, Blood. 2000;96:2269-2276.
42. Tanaka S, Takasu Y, Mikura S, Satoh N, Ichikawa A. Antigen-independent induction of histamine synthesis by immunoglobulin E in mouse bone marrow-derived mast cells, J Exp Med, 2002;196:229-235.
43. Costello PS, Turner M, Walters AE, et al. Critical role for the tyrosine kinase Syk in signalling through the high affinity IgE receptor of mast cells. Oncogene. 1996;13:2595-2605.
44. 2+ mobilization, but not degranulation, in lyn-deficient bone marrow-derived mast cells. J Immunol. 1997;158:2350-2355.
45. Odom S, Gomez G, Kovarova M, et al. Negative regulation of immunoglobufin E-dependent allergic responses by Lyn kinase. J Exp Med. 2004;199:1491-1502.
46. Koike T, Yamagishi H, Hatanaka Y, et al. A novel ERK-dependent signaling process that regulates interleukin-2 expression in a late phase of T cell activation. J Biol Chem. 2003;278:15685-15692.
47. Rosa Santos SC, Dumon S, Mayeux R, Gisselbrecht S, Gouilleux F. Cooperation between STAT5 and phosphatidylinositol 3-kinase in the IL-3-dependent survival of a bone marrow derived cell line. Oncogene. 2000;19:1164-1172.
48. Dumon S, Santos SC, Debierre-Grockiego F, et al. IL-3 dependent regulation of Bcl-xLgene expression by STAT5 in a bone marrow derived cell line. Oncogene. 1999;18:4191-4199.
49. Shelburne CP, McCoy ME, Piekorz R, et al. Stat5 expression is critical for mast cell development and survival. Blood. 2003;102:1290-1297.
50. Dombrowicz D, Flamand V, Brigman KK, Koller BH, Kinet JP. Abolition of anaphylaxis by targeted disruption of the high affinity immunoglobulin E receptor alpha chain gene. Cell. 1993;75:969-976.
51. Bryce PJ, Miller ML, Miyajima I, Tsai M, Galli SJ, Oettgen HC. Immune sensitization in the skin is enhanced by antigen-independent effects of IgE. Immunity. 2004;20:381-392.
52. Nawa Y, Ishikawa N, Tsuchiya K, et al. Selective effector mechanisms for the expulsion of intestinal helminths. Parasite Immunol. 1994;16:333-338.
53. Ehigiator HN, Stadnyk AW, Lee TD. Extract of Nippostrongylus brasiliensis stimulates polyclonal type-2 immunoglobulin response by inducing de novo class switch. Infect Immun. 2000;68:4913-4922.
54. Perrudet-Badoux A, Binaghi RA, Boussac-Aron Y. Trichinella spiralis infection in mice: mechanism of the resistance in animals genetically selected for high and low antibody production. Immunology. 1978;35:519-522.
55. Watanabe N, Katakura K, Kobayashi A, Okumura K, Ovary Z. Protective immunity and eosinophilia in IgE-deficient SJA/9 mice infected with Nippostrongylus brasiliensis and Trichinella spiralis. Proc Natl Acad Sci USA. 1988;85:4460-4462.
56. Onah DN, Uchiyama F, Nagakui Y, Ono M, Takai T, Nawa Y. Mucosal defense against gastrointestinal nematodes: responses of mucosal mast cells and mouse mast cell protease 1 during primary strongyloides venezuelensis infection in FcR-gamma-knockout mice. Infect Immun. 2000;68:4968-4971.
57. Gurish MF, Bryce PJ, Tao H, et al. IgE enhances parasite clearance and regulates mast cell responses in mice infected with Trichinella spiralis. J Immunol. 2004;172:1139-1145.
58. Przybilla B, Ring J, Volk M. [Total IgE levels in the serum in dermatologie diseases]. Hautarzt. 1986;37:77-82.